Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum]

Niu S, Ren Q, Chen S, et al. Diabetes Metab Syndr Obes. 2023;16:2549–2560. The authors have advised the correspondence section on page 2549 is incorrect. The correct correspondence details are as follows. Correspondence: Shuchun Chen, Department of Endocrinology, Hebei General Hospital, S...

Full description

Bibliographic Details
Main Authors: Niu S, Ren Q, Chen S, Pan X, Yue L, Chen X, Li Z, Zhen R
Format: Article
Language:English
Published: Dove Medical Press 2023-09-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
Online Access:https://www.dovepress.com/corrigendum-metabolic-and-hepatic-effects-of-empagliflozin-on-nonalcoh-peer-reviewed-fulltext-article-DMSO
_version_ 1797682530511486976
author Niu S
Ren Q
Chen S
Pan X
Yue L
Chen X
Li Z
Zhen R
author_facet Niu S
Ren Q
Chen S
Pan X
Yue L
Chen X
Li Z
Zhen R
author_sort Niu S
collection DOAJ
description Niu S, Ren Q, Chen S, et al. Diabetes Metab Syndr Obes. 2023;16:2549–2560. The authors have advised the correspondence section on page 2549 is incorrect. The correct correspondence details are as follows. Correspondence: Shuchun Chen, Department of Endocrinology, Hebei General Hospital, Shijiazhuang, Hebei, People’s Republic of China, Email chenshuc2014@163.com The authors apologize for this error.
first_indexed 2024-03-12T00:02:11Z
format Article
id doaj.art-70c2babf72a34532ba0f7531bbe1e1a0
institution Directory Open Access Journal
issn 1178-7007
language English
last_indexed 2024-03-12T00:02:11Z
publishDate 2023-09-01
publisher Dove Medical Press
record_format Article
series Diabetes, Metabolic Syndrome and Obesity
spelling doaj.art-70c2babf72a34532ba0f7531bbe1e1a02023-09-17T16:39:52ZengDove Medical PressDiabetes, Metabolic Syndrome and Obesity1178-70072023-09-01Volume 162833283486737Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum]Niu SRen QChen SPan XYue LChen XLi ZZhen RNiu S, Ren Q, Chen S, et al. Diabetes Metab Syndr Obes. 2023;16:2549–2560. The authors have advised the correspondence section on page 2549 is incorrect. The correct correspondence details are as follows. Correspondence: Shuchun Chen, Department of Endocrinology, Hebei General Hospital, Shijiazhuang, Hebei, People’s Republic of China, Email chenshuc2014@163.com The authors apologize for this error.https://www.dovepress.com/corrigendum-metabolic-and-hepatic-effects-of-empagliflozin-on-nonalcoh-peer-reviewed-fulltext-article-DMSOnafldempagliflozinmetabolomicsdifferentially expressed metabolitesobesity
spellingShingle Niu S
Ren Q
Chen S
Pan X
Yue L
Chen X
Li Z
Zhen R
Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum]
Diabetes, Metabolic Syndrome and Obesity
nafld
empagliflozin
metabolomics
differentially expressed metabolites
obesity
title Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum]
title_full Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum]
title_fullStr Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum]
title_full_unstemmed Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum]
title_short Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum]
title_sort metabolic and hepatic effects of empagliflozin on nonalcoholic fatty liver mice corrigendum
topic nafld
empagliflozin
metabolomics
differentially expressed metabolites
obesity
url https://www.dovepress.com/corrigendum-metabolic-and-hepatic-effects-of-empagliflozin-on-nonalcoh-peer-reviewed-fulltext-article-DMSO
work_keys_str_mv AT nius metabolicandhepaticeffectsofempagliflozinonnonalcoholicfattylivermicecorrigendum
AT renq metabolicandhepaticeffectsofempagliflozinonnonalcoholicfattylivermicecorrigendum
AT chens metabolicandhepaticeffectsofempagliflozinonnonalcoholicfattylivermicecorrigendum
AT panx metabolicandhepaticeffectsofempagliflozinonnonalcoholicfattylivermicecorrigendum
AT yuel metabolicandhepaticeffectsofempagliflozinonnonalcoholicfattylivermicecorrigendum
AT chenx metabolicandhepaticeffectsofempagliflozinonnonalcoholicfattylivermicecorrigendum
AT liz metabolicandhepaticeffectsofempagliflozinonnonalcoholicfattylivermicecorrigendum
AT zhenr metabolicandhepaticeffectsofempagliflozinonnonalcoholicfattylivermicecorrigendum